Endothelial Nitric Oxide Synthase and Angiotensinogen Gene Polymorphism in Coronary Artery Diseases in Egypt

被引:17
作者
Motawi, Tarek [2 ]
Shaker, Olfat [1 ]
Taha, Mohamed [2 ]
Sedrak, Heba
Nabil, Mai [3 ]
机构
[1] Cairo Univ, Dept Med Biochem, Fac Med, Cairo, Egypt
[2] Cairo Univ, Dept Biochem, Fac Pharm, Cairo, Egypt
[3] CAPA, Cairo, Egypt
关键词
coronary artery disease; endothelial nitric oxide synthase; angiotensinogen; polymorphism; M235T POLYMORPHISM; GLU298ASP POLYMORPHISM; COMMON VARIANT; RISK-FACTOR; ASSOCIATION; SEVERITY; ATHEROSCLEROSIS; HYPERTENSION; TAIWANESE; SYSTEM;
D O I
10.1177/0003319710373094
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Genetic factors contribute to the pathogenesis of coronary artery disease (CAD). We studied 100 patients with CAD and 50 healthy individuals to assess the association of endothelial nitric oxide (eNOS) polymorphism (Glu298Asp) and angiotensinogen polymorphisms (M235T) and CAD in an Egyptian population. Serum nitric oxide (NO) and angiotensin I levels were also measured. The frequency of Glu298Asp and M235T polymorphisms were higher in the CAD group compared with controls. The mean level of NO was significantly lower (P < .05) while angiotensin I was significantly higher (P < .05) in patients CAD than in controls. The frequency of eNOS TT allele of M235T variant was significantly higher in patients with CAD (20% vs 6%). The frequency of angiotensinogen (AGT) TT and T allele in patients with CAD was significantly higher (P < .05) than in controls (22% vs 6%and 47% vs23%, respectively). Homozygosity for Glu298Asp and M235T polymorphisms may predispose to CAD.
引用
收藏
页码:191 / 197
页数:7
相关论文
共 30 条
[1]   NO level and endothelial NO synthase gene polymorphism (Glu298Asp) in the patients with coronary artery disease from the Turkish population [J].
Afrasyap, L ;
Ozturk, G .
ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2004, 36 (10) :661-666
[2]   Angiotensin converting enzyme I/D, angiotensinogen T174M-M235T and angiotensin II type 1 receptor A1166C gene polymorphisms in Turkish hypertensive patients [J].
Agachan, B ;
Isbir, T ;
Yimaz, H ;
Akoglu, E .
EXPERIMENTAL AND MOLECULAR MEDICINE, 2003, 35 (06) :545-549
[3]  
Arora S, 2009, INT J COLLAB RES INT, V1, P56
[4]  
Buraczynska Monika, 2003, Kardiol Pol, V58, P1
[5]   The Glu298Asp polymorphism in the endothelial nitric oxide synthase gene is strongly associated with coronary spasm [J].
Chang, KY ;
Baek, SH ;
Seung, KB ;
Kim, PJ ;
Ihm, SH ;
Chae, JS ;
Kim, JH ;
Hong, SJ ;
Choi, KB .
CORONARY ARTERY DISEASE, 2003, 14 (04) :293-299
[6]   Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298→Asp polymorphism) to the presence, extent, and severity of coronary artery disease [J].
Colombo, MG ;
Andreassi, MG ;
Paradossi, U ;
Botto, N ;
Manfredi, S ;
Masetti, S ;
Rossi, G ;
Clerico, A ;
Biagini, A .
HEART, 2002, 87 (06) :525-528
[7]   Role of endothelial dysfunction in atherosclerosis [J].
Davignon, J ;
Ganz, P .
CIRCULATION, 2004, 109 (23) :27-32
[8]   Both alleles of the M235T polymorphism of the angiotensinogen gene can be a risk factor for myocardial infarction [J].
Fernández-Arcás, N ;
Dieguez-Lucena, JL ;
Muñoz-Morán, E ;
Ruiz-Galdón, M ;
Espinosa-Caliani, S ;
Aranda-Lara, P ;
Rius-Diaz, F ;
Gaitán-Arroyo, MJ ;
De Teresa-Galván, E ;
Reyes-Engel, A .
CLINICAL GENETICS, 2001, 60 (01) :52-57
[9]   The T allele of the missense Glu298Asp endothelial nitric oxide synthase gene polymorphism is associated with coronary heart disease in younger individuals with high atherosclerotic risk profile [J].
Gardemann, A ;
Lohre, J ;
Cayci, S ;
Katz, N ;
Tillmanns, H ;
Haberbosch, W .
ATHEROSCLEROSIS, 2002, 160 (01) :167-175
[10]  
Gluba A, 2009, IN VIVO, V23, P797